KESELAMATAN ASAL ADAM AMINI DIPANGGIH kanggo protein sintesis
Detail Produk
| NO | Produk | Cas no | Indikator Kunci Key | |||
| Kemurnian | Max. DEVUCT | Sisa Solvent | Kelembapan | |||
| 1 | FMOC-β-ala-ala-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 2 | FMOC-D-ala-D-ala-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 3 | FMOC-β-D-ala-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 4 | FMOC-ARG (PBF) -arg (PBF) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 5 | FMOC-β-ARG (PBF) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 6 | FMOC-D-ARG (PBF) -D-ARG (PBF) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 7 | FMOC-β-D-Arg (PBF) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 8 | FMOC-HomoIarg (PBF) -homoarg (PBF) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 9 | FMOC-β-Homoarg (PBF) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 10 | Fmoc-asn (Trt) -asn (Trt) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 11 | FMOC-β-asn (Trt) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 12 | FMOC-ASP (OTBU) -Asp (OTBU) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 13 | FMOC-β-ASP (OTBU) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 14 | FMOC-CYS (TRT) -cys (Trt) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 15 | FMOC-β-ala-Cys (TrT) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 16 | FMOC-CYS (ACM) -cys (ACM) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 17 | FMOC-β-ala-Cys (ACM) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 18 | FMOC-GLN (TRT) -GLN (TRT) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 19 | FMOC-β-GLN (TRT) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 20 | FMOC-Glu (Otbu) -Glu (OTBU) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 21 | FMOC-β-Glu (OTBU) -OH.H2O | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 22 | FMOC-β-Ala-Gly-Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 23 | FMOC-HIS (TRT) -His (Trt) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 24 | FMOC-β-ala-HIS (TRT) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 25 | FMOC-ILE-ILE-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 26 | FMOC-β-β-Ile-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 27 | FMOC-leu-leu-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 28 | FMOC-β-LEU-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 29 | FMOC-D-Luu-D-Leu-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 30 | FMOC-β-ala-d-luu-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 31 | FMOC-Lys (BOC) -LYS (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 32 | FMOC-β-Ala-Lys (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 33 | FMOC-Lys (alloc) -lys (alloc) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 34 | FMOC-β-Ala-Lys (alloc) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 35 | Fmoc-met-met-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 36 | FMOC-β-ala-met-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 37 | FMOC-Orn (BOC) -orn -oh -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 38 | FMOC-β-Orn (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 39 | FMOC-PHE-PHE-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 40 | FMOC-β-β-phe-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 41 | FMOC-D-PHE-D-PHE-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 42 | FMOC-β-ala-D-Phhe-Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 43 | FMOC-PRO-PRO-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 44 | FMOC-β-PRO-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 45 | FMOC-Ser (TBU) -ser (TBU) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 46 | FMOC-β-Ser (TBU) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 47 | FMOC-Ser (Trt) -ser (Trt) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 48 | FMOC-β-Ser (Trt) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 49 | FMOC-thr (TBU) -thr (TBU) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 50 | FMOC-β-A-thr (TBU) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 51 | FMOC-TRP (BOC) -TRP (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 52 | FMOC-β-TRP (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 53 | FMOC-D-TRP (BOC) -D-TRP (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 54 | FMOC-β-D-TRP (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 55 | FCHOC-TYR (TBU) -tyr (TBU) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 56 | FMOC-β-ala-tyr (TBU) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 57 | FMOC-D-TYR (ET) -D-tyr (et) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 58 | FMOC-β-D-TYR (et) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 59 | FMOC-TYR (ME) -ty -TY -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 60 | FMOC-β-ala-tyr (kula) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 61 | FMOC-VAL-VAL-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 62 | FMOC-β-ALA-VAL-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 63 | FMOC-D-Cit-D-Cit-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 64 | FMOC-β-ala-D-Cit-oh Cit-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 65 | FMOC-β-ala-dab-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 66 | FMOC- (3- (2 Naphthyl) -d-ala) 2-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 67 | FMOC-β-3- (2-Naphthyl) -d-Ala-Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 68 | FMOC- (3- (3-pyridinyl) -d-ala) 2-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 69 | FMOC-β-A-3- (3-Pyridinyl) -D-Ala-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 70 | FMOC- (4-Chlororo-D-Phhe) 2-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 71 | FMOC-β-ala-4-chlororo-d-phe-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 72 | FMOC- (D-4HH (TBUBM)) 2-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 73 | FMOC-β-D-4aph (Tbucbm) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 74 | FMOC-APH (L-HOR) -ApH (L-Hor) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 75 | FMOC-β-AL-APH (L-HOR) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 76 | FMOC-Lys (IPR, BOC) -ly (IPR, BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 77 | FMOC-β-Ala-Lys (IPR, BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 78 | FMOC-β-Aeea-Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 79 | FMOC-AIB-AIB-AIB-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 80 | FMOC-β-AIB-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 81 | FMOC-oh | 91000-69-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 82 | H-Arg (PBF) -Oh | 200115-86-2 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 83 | FMOC-D-arg-oh | 130752-32-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 84 | HD-arg (pbf) -Oh | 200116-81-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 85 | FMOC-HOMOIARG-OH.HCL | 208174-14-5 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 86 | H-homoarg (PBF) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 87 | FMOC-D-HomoIarg-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 88 | HD-Homoarg (PBF) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 89 | FMOC-ASN-OH | 71989-16-7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 90 | H-asn (Trt) -Oh | 132388-58-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 91 | FMOC-ASP-OH | 119062-05-4 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 92 | H-ASP (OTBU) -OH | 3057-74-7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 93 | FMOC-CYS-OH | 135248-89-4 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 94 | H-Cys (Trt) -Oh | 2799/7/7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 95 | H-Cys (ACM) -OH.HCL | 28798-28-9 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 96 | FMOC-GLN-OH | 71989-20-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 97 | H-Gln (Trt) -Oh | 102747-84-2 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 98 | FMOC-Glu-OH | 121343-82-6 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 99 | H-Glu (Otbu) -OH.H2O | 2419-56-9 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 100 | FMOC-HIS | 116611-64-4 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 101 | H-Hisy (Trt) -Oh | 35146-32-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 102 | Boc-His-Oh | 17791-52-5 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 103 | FMOC-Lys-OH | 105047-45-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 104 | H-Lys (BOC) -OH | 2418-95-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 105 | H-Lys (alloc) -Oh | 6298/3/9 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 106 | FMOC-Orn-OH.HCL | 201046-57-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 107 | H-orn (BOC) -OH | 13650-4-2 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 108 | FMOC-Ser-OH | 73724-45-5 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 109 | H-Ser (TBU) -Oh | 18822-58-7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 110 | H-Ser (Trt) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 111 | FMOC-thr-oh.h2o | 73731-37-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 112 | H-thr (TBU) -Oh | 4378-13-6 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 113 | FMOC-TRP-OH | 35737-15-6 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 114 | H-TRP (BOC) -OH | 146645-63-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 115 | FMOC-D-TRP-OH | 86123-11-7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 116 | HD-TRP (BOC) -OH | 201290-11-1 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 117 | FMOC-Tyr-OH | 92954-90-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 118 | H-tyr (TBU) -Oh | 18822-59-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 119 | FMOC-D-Tyr-OH | 112883-29-1 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 120 | HD-tyr (et) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 121 | H-tyr (kula) -Oh.hcl | 67423-4-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 122 | FMOC-D-4aph (CBM) -Oh | 324017-22-3-3-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 123 | HD-4Aph (TBUBM) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 124 | FMOC-Lys (IPR) -Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 125 | H-Lys (IPR, BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
Babagan
Kompensasi
Gentolex nyedhiyakake produk berkualitas sing apik, yen kualitas produk digedhekake dening klien ing pigura wektu sing dibutuhake kanthi bukti sing cukup, kita bakal menehi analisis sing cukup, kita bakal menehi analisis sing cukup lan evaluasi kanggo micu prosensasi.
Produksi
Kapasitas produk farmasi ngrambah kelas ton, kapasitas produk kimia tekan 100ton + kelas, kapabilitas sing dilengkapi kanggo ngladeni ing saindenging jagad.
Riset lan pangembangan
Saben taun, ana rencana sing disiyapake dening tim R & D kanggo ngembangake produk anyar sing beda, nalika target nyetel, saben anggota tim kudu nindakake tanggung jawab KPI lan kanthi kabijakan.
